RT @ASBMR: Results from a new #JBMRPlus study support the use of abaloparatide as the initial treatment in sequential therapy with alendronate in women with PMO at very high fracture risk #openaccess #freetoread @GalgoMedical @UMichDentistry https://t.co/BR93zYDDOT https://t.co/XB4Chhqgri
RT @ASBMR: Results from a new #JBMRPlus study support the use of abaloparatide as the initial treatment in sequential therapy with alendronate in women with PMO at very high fracture risk #openaccess #freetoread @GalgoMedical @UMichDentistry https://t.co/BR93zYDDOT https://t.co/XB4Chhqgri
— Gaston Ramirez (@GastonR48222321) Feb 22, 2022
from Twitter https://twitter.com/GastonR48222321
February 22, 2022 at 05:26PM
Comentarios
Publicar un comentario